NCT05162573View on ClinicalTrials.gov

EBRT + Lu-PSMA for N1M0 Prostate Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 20, 2021

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2025

Conditions
Prostatic Neoplasm
Interventions
DRUG

177Lu-PSMA-617

Dose-escalation of 177Lu-PSMA-617 (3, 6, 9 or 2x7.4 GBq) combined with external beam radiotherapy (EBRT)

RADIATION

EBRT

External Beam Radiotherapy

Trial Locations (2)

1066 CX

RECRUITING

Netherlands Cancer Institute, Amsterdam

3508 GA

RECRUITING

UMC Utrecht, Utrecht

Sponsors
All Listed Sponsors
collaborator

UMC Utrecht

OTHER

collaborator

Advanced Accelerator Applications

INDUSTRY

lead

The Netherlands Cancer Institute

OTHER